FdaApplication
NDA 208025
Identifiers
- fda_app_no: NDA208025
Properties
| Property | Value |
|---|---|
| applicant_name | DEXCEL PHARMA TECHNOLOGIES LTD |
| application_type | NDA |
| approval_date | 2016-06-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LANSOPRAZOLE | LANSOPRAZOLE | 15MG | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL |
1 product